Navigating the global shift: prospects and challenges in the clinical research enterprise
DOI:
https://doi.org/10.18203/2349-3259.ijct20253340Keywords:
Clinical trials, Developing countries, Ethical challenges, Globalization, Infrastructure, Regulatory frameworkAbstract
In recent years, the conduct of clinical trials in developing countries has increased markedly, reflecting a broader shift of the clinical research enterprise toward non-traditional geographic regions. This expansion is driven by multiple factors including greater availability of research participants, decreased costs of conducting research and, in some cases, less restrictive regulatory environments. While these underlying forces present valuable opportunities to the clinical research enterprise system, they also introduce complex scientific, ethical, and regulatory challenges. Nevertheless, if the challenges are navigated prudently, the globalization of clinical research trials may hold considerable potential to accelerate the development of innovative medical therapies that could contribute meaningfully to addressing the global health needs.
Metrics
References
Younis IM. Overview of Research Committees Status in Egypt: Challenges Aspirations and Current Situation. Account Res. 2015;22(4):222-36. DOI: https://doi.org/10.1080/08989621.2014.956869
Ballantyne AJ. How to Do Research Fairly in an Unjust World. Am J Bioeth. 2010;10(6):26-35. DOI: https://doi.org/10.1080/15265161.2010.482629
Adobor H. Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry. J Bus Ethics. 2011;105(2):239-55. DOI: https://doi.org/10.1007/s10551-011-0964-0
Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lang T. The challenges and opportunities of conducting a clinical trial in a low resource setting: The case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator-initiated trial. Trials. 2011;12:145. DOI: https://doi.org/10.1186/1745-6215-12-145
Bhatt A. Evolution of clinical research: a history before and beyond James Lind. Persp Clin Res. 2010;1(1):6-10. DOI: https://doi.org/10.4103/2229-3485.71839
Schuklenk U, Ashcroft R. International research ethics. Bioethics. 2000;14(2):158-72. DOI: https://doi.org/10.1111/1467-8519.00187
Weigmann K. The ethics of global clinical trials. EMBO Reports. 2015;16(5):566-570. DOI: https://doi.org/10.15252/embr.201540398
Vijayananthan A, Nawawi O. The importance of Good Clinical Practice guidelines and its role in clinical trials. Biomed Imag Inter J. 2008;4(1):64. DOI: https://doi.org/10.2349/biij.4.1.e5
Altavilla. Ethical key issues and fundamental rights in pediatric research. Euro J Clin Pharmacol. 2010;67(1):117-23. DOI: https://doi.org/10.1007/s00228-010-0929-8
Laws S, Marcus R, Jones N, Harper C. Research for development: A practical guide. 2013. DOI: https://doi.org/10.4135/9781529681406
Van der Graaf R, van Delden JJM. What is the best standard of care in clinical research. Am J Bioeth. 2009;9(3):35-43. DOI: https://doi.org/10.1080/15265160802654129
Wendler D, Emanuel EJ, Lie RK. The standard of care debate: can research in developing countries be both ethical and responsive to those countries’ health needs. Am J Public Health. 2004;94(6):923-8. DOI: https://doi.org/10.2105/AJPH.94.6.923
Usharani P, Naqvi SM. Post-trial access. Perspectives Clin Res. 2013;4(1):58. DOI: https://doi.org/10.4103/2229-3485.106391
Igoumenidis, S. Zyga. Healthcare research in developing countries: Ethical issues. Health Sci J. 2011;5(4):243250.
Sanchez S, Salazar G, Tijero M, Diaz S. Informed Consent Procedures: Responsibilities of researchers in developing countries. Bioethics. 2001;15(6):398-412. DOI: https://doi.org/10.1111/1467-8519.00250
Udo Schuklenk. For-Profit Clinical Trials in Developing Countries—Those troublesome patient benefits. Am J Bioeth. 2010;10(6):52-4. DOI: https://doi.org/10.1080/15265161.2010.483183
Emanuel Ezekiel J, Wendler D, Killen J, Grady C. What makes clinical research in developing countries ethical. The benchmarks of ethical research. J Infecti Dis. 2004;189(5):930-7. DOI: https://doi.org/10.1086/381709
Emanuel EJ, Currie XE, Herman A; Project Phidisa. Undue inducement in clinical research in developing countries: is it a worry. Lancet. 2005;366(9482):336-40. DOI: https://doi.org/10.1016/S0140-6736(05)66992-9
Bentley JP, Thacker PG. The influence of risk and monetary payment on the research participation decision making process. J Med Ethics. 2004;30(3):293-8. DOI: https://doi.org/10.1136/jme.2002.001594
Glickman SW, McHutchison JG, Peterson ED. Ethical and scientific implications of the globalization of clinical research. New England J Med. 2009;360(8):816-23. DOI: https://doi.org/10.1056/NEJMsb0803929
Gilman RH. Ethics review procedures for research in developing countries: a basic presumption of guilt. Canadian Med Asso J. 2004;171(3):248-9. DOI: https://doi.org/10.1503/cmaj.1031121
Perrey C, Wassenaar D, Gilchrist S, Ivanoff B. Ethical issues in medical research in the developing world: a report on a meeting organized by fondation mérieux. Dev World Bioeth. 2009;9(2):88-96. DOI: https://doi.org/10.1111/j.1471-8847.2008.00229.x
Egharevba E, Atkinson J. The role of corruption and unethical behavior in precluding the placement of industry sponsored clinical trials in sub-Saharan Africa: Stakeholder views. Contemp Clin Trial Comm. 2016;3:102-10. DOI: https://doi.org/10.1016/j.conctc.2016.04.009
Caballero B. Ethical issues for collaborative research in developing countries. Am J Clin Nutr. 2002;76(4):717-20. DOI: https://doi.org/10.1093/ajcn/76.4.717
Dunmade IS, Fayomi OS. Lifecycle engineering of infrastructure: an essential approach to engineering for a sustainable Africa. InIOP Conference Series: Mat Sci Engin. 2018;3:91. DOI: https://doi.org/10.1088/1757-899X/391/1/012010
Rosa C, Campbell AN, Miele GM, Brunner M, Winstanley EL. Using e-technologies in clinical trials. Contemporary Clin Trial. 2015;45:41-54. DOI: https://doi.org/10.1016/j.cct.2015.07.007
O'Brien C, Furlong E, Coughlan B, Fox P, Darley A. Building research capacity and culture: Exploring nurses' experience of implementing a nurse‐led clinical trial. J Nurs Man. 2022;30(4):1002-10. DOI: https://doi.org/10.1111/jonm.13576